Pharmacogenomic Testing

Pharmacogenomic testing — also called pharmacogenetics or PGx testing — analyzes specific variations in your DNA that affect how your body metabolizes, responds to, and tolerates psychiatric medications. The core insight behind PGx is that individual genetic differences in liver enzymes (particularly the CYP450 enzyme family, such as CYP2D6 and CYP2C19) cause the same medication dose to have vastly different effects in different people. A dose that is therapeutic for one person may be sub-therapeutic — or cause toxicity — in another, based on their genetic profile.

The test itself is non-invasive: a simple cheek swab collected at home is mailed to a certified laboratory. Results typically return within 5–7 business days and classify your metabolism of various drug classes as "poor," "intermediate," "normal," or "ultra-rapid." Your PMHNP at Hometown NP will interpret these results in the context of your full clinical picture — your diagnosis, current symptoms, medical history, and other medications — to generate a more personalized prescribing strategy. This can significantly reduce the trial-and-error process that often accompanies psychiatric medication selection.

Pharmacogenomic testing does not predict whether you will develop a mental health condition, nor does it tell your provider which diagnosis you have. What it does is help narrow the field of medications most likely to work well for you, minimize the risk of adverse effects driven by genetic metabolism differences, and inform dosing decisions. Testing is especially useful for patients who have had multiple medication failures or unusual responses to standard doses.